Egidia Miftode
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Clostridium difficile and Clostridium perfringens research 8
- COVID-19 Clinical Research Studies 5
- Epidemiology 21
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Olivia Dorneanu (23 shared papers)Ionela-Larisa Miftode (20 shared papers)Eduard Vasile Năstase (9 shared papers)Irina Gîrleanu (5 shared papers)Anca Trifan (8 shared papers)C Stanciu (6 shared papers)Camelia Cojocariu (4 shared papers)Oana Stoica (3 shared papers)
In The Last Decade
Egidia Miftode
61 papers receiving 406 citations
Peers
Comparison fields: 5 of 76
- Applied Microbiology and Biotechnology 32
- Molecular Medicine 58
- Infectious Diseases 147
- Microbiology 41
- Hepatology 34
Countries citing papers authored by Egidia Miftode
This map shows the geographic impact of Egidia Miftode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egidia Miftode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egidia Miftode more than expected).
Fields of papers citing papers by Egidia Miftode
This network shows the impact of papers produced by Egidia Miftode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egidia Miftode. The network helps show where Egidia Miftode may publish in the future.
Co-authors
The 25 scholars most cited alongside Egidia Miftode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 49 | |
| 2 | 2015 | 31 | |
| 3 | 2021 | 25 | |
| 4 | 2023 | 24 | |
| 5 | 2017 | 18 | |
| 6 | 2024 | 17 | |
| 7 | 2023 | 17 | |
| 8 | 2021 | 17 | |
| 9 | 2023 | 12 | |
| 10 | COVID-19: A COURSE THROUGH STORMY WATERS | 2020 | 12 |
| 11 | Clinical features and course of bacterial meningitis in children. | 2013 | 10 |
| 12 | 2015 | 10 | |
| 13 | [Antimicrobial resistance profile of E. coli and Klebsiella spp. from urine in the Infectious Diseases Hospital Iaşi]. | 2009 | 10 |
| 14 | 2021 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2017 | 7 | |
| 19 | Optimization of triplex real time PCR for detecting Staphylococcus aureus mecA, pvl and nuc genes. | 2011 | 7 |
| 20 | 2023 | 6 |
About Egidia Miftode
Egidia Miftode is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Public Health, Environmental and Occupational Health and Hepatology, having authored 71 papers that have together received 412 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Clostridium difficile and Clostridium perfringens research (8 papers), Hepatitis C virus research (8 papers), Antibiotic Use and Resistance (6 papers), Hepatitis B Virus Studies (5 papers), Infectious Diseases and Tuberculosis (5 papers), COVID-19 Clinical Research Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (32 citations), Molecular Medicine (58 citations), Infectious Diseases (147 citations), Microbiology (41 citations) and Hepatology (34 citations). Egidia Miftode has collaborated with scholars based in Romania, Russia and Japan. Frequent co-authors include Olivia Dorneanu, Ionela-Larisa Miftode, Eduard Vasile Năstase, Irina Gîrleanu, Anca Trifan, C Stanciu, Camelia Cojocariu, Oana Stoica, Radu-Ştefan Miftode and Ana-Maria Sîngeap. Their work appears in journals such as Revista de Cercetare si Interventie Sociala, Antibiotics, International Journal of Molecular Sciences, Frontiers in Immunology and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.